Systematic Review
Published on 21 Dec 2023
Efficacy and safety of novel carbapenem-β-lactamase inhibitor combinations: imipenem-cilastatin/relebactam results from randomized controlled trials
in Infectious Diseases: Pathogenesis and Therapy
- 2,008 views
- 2 citations